{
  "docId": "019de514-833c-7520-a4a9-200b68fbb681",
  "docSlug": "d869e39fe11534a9d64784c9e4f475f2",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 47 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 33,
  "pageCount": 47,
  "prevPage": 32,
  "nextPage": 34,
  "slideType": "revenue_buildup",
  "function": "decompose_segments",
  "density": "dense",
  "nDataPoints": 75,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de514-833c-7520-a4a9-200b68fbb681/33",
  "deckHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681",
  "deckJsonHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681.json",
  "deckAnchorHref": "/decks/019de514-833c-7520-a4a9-200b68fbb681#slide-33",
  "components": [
    {
      "bbox": {
        "h": 0.02,
        "w": 0.099,
        "x": 0.043,
        "y": 0.94
      },
      "kind": "image",
      "text": "BAUSCH+ LOMB",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "58eb1c27-aceb-44bc-affe-588b7e304458",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.095,
        "w": 0.789,
        "x": 0.15,
        "y": 0.878
      },
      "kind": "source-note",
      "text": "1. Products with sales outside the United States impacted by F/X changes.\n2. This is a non-GAAP measure or ratio. See Slide 2 and Appendix for further information on non-GAAP measures and ratios.\n3. Includes transactional FX and NCI.\n4. On a proforma basis after giving effect to the IPO.\n5. Organic revenue growth/change, a non-GAAP ratio, is defined as a change on a period-over-period basis in revenues on a constant currency basis (if applicable) excluding the impact of acquisitions, divestitures and discontinuations.\n6. Prior to 2022, in calculating this non-GAAP measure/ratio, the Company had excluded expenses associated with acquired IPR&D. Commencing in 2022, the Company no longer excludes acquired IPR&D in calculating these amounts. The Company believes these costs are not material for the periods presented. See the Appendix for further information on this change.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "529a2ca0-7bc7-4f02-bca7-89d4ec49c5ba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.702,
        "w": 0.898,
        "x": 0.047,
        "y": 0.145
      },
      "kind": "table",
      "text": "Bausch + Lomb 3Q22-1Q22 3Q21-1Q21 Reported Change Constant Currency³ Organic Change 3,5 Vision Care Revenue $1,747M $1,717M 2% 7% 7% Surgical Revenue $530M $520M 2% 8% 9% Ophthalmic Pharmaceuticals Revenue $495M $527M (6%) (3%) (3%) Total Revenue $2,772M $2,764M 0% 5% 5% Adj. Gross Profit2 $1,673M $1,700M (2%) 2% Adj. Gross Margin² 60.4% 61.5% (110 bps) R&D $229M $201M (14%) (17%) R&D percent of Revenues 8.3% 7.3% Adj. SG&A2 $1,060M $1,016M (4%) (9%) Adj. SG&A percent of Revenues2 38.2% 36.8% Adj. EBITA 2,6 $383M $483M (21%) (18%) Depreciation $98M $90M 9% 14% Stock Based Compensation $45M $45M 0% 0% Adj. EBITDA 2,3,6 $539M $605M (11%) (14%) Adj. EBITDA Margin2,6 19.4% 21.9% Adj. Net Income 3,6 $295M $333M (11%) (16%) Adj EPS2,4,6 $0.84 $0.95",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e8bf5f08-24de-40e7-946e-ee9919304d7e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.709,
        "x": 0.047,
        "y": 0.047
      },
      "kind": "title",
      "text": "Total Bausch + Lomb P&L¹ (Non-GAAP)² - YTD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed2f7469-9a9a-4abc-899c-340c89de8272",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "c9c449d2-e123-40cc-b3f9-8d3bfebfb52f",
      "evidence": "table/data: Bausch + Lomb",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}